Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New VP of immunology and fibrosis at Regulus

This article was originally published in Scrip

Executive Summary

Regulus Therapeutics, a La Jolla, California-based biopharmaceutical company focused on the discovery and development of medicines targeting microRNAs, has appointed Dr Lars Karlsson vice-president of immunology and fibrosis. Dr Karlsson, who has more than 20 years' research and pharmaceutical experience, was at Johnson and Johnson Pharmaceutical Research and Development from 1994 until this year, most recently serving as team leader of the company's west coast immunology department and senior research fellow, where he was responsible for projects from discovery until clinical proof-of-concept. Before that, he spent seven years as a researcher at the Scripps Research Institute in the Department of Immunology.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC012355

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel